Addressing the Risks in Your Life Science Supply Chain with AstraZeneca

How are you mitigating your risks?
From compliance to onboarding, supplier reliability to cost, the life sciences industry is facing numerous risks in 2021. How are you dealing with them? It’s more important than ever to make sure you’re mitigating risks and staying competitive.
- Paul Armstrong, Director, Digital Procurement, AstraZeneca
- Laurent Charmes, Senior Manager, Risk Management BearingPoint
- Francesco Colavita, VP PreSales and Bid Management, JAGGAER
Hear directly from AstraZeneca on how they’ve minimized risk in their supply chains by taking an innovative approach. See what lessons you can learn from their digitization to start building a sustainable and efficient workflow.
In this 45-minute round table, you’ll learn:
- What risks pharmaceutical companies face in today’s market
- How you can evaluate and mitigate your risks
- How AstaZeneca is leveraging Category Management and Sourcing
- How technological innovation can minimize risk exposure
More On-Demand Webinars
Maturity Assessment
Take this quick Autonomous Commerce Maturity Assessment now to identify your maturity stage and the next steps to take in your journey.